Characteristics of Novel Therapeutics and Postmarket Safety Events.
- 19 September 2017
- journal article
- other
- Published by American Medical Association (AMA) in JAMA
- Vol. 318 (11), 1067
- https://doi.org/10.1001/jama.2017.11513
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010JAMA, 2017
- Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012JAMA, 2014
- Regulatory Review of Novel Therapeutics — Comparison of Three Regulatory AgenciesThe New England Journal of Medicine, 2012